Gradient Investments LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 177 filers reported holding TG THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.

Quarter-by-quarter ownership
Gradient Investments LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$17
-99.8%
2
-99.4%
0.00%
Q2 2023$7,750
+10.1%
312
-33.3%
0.00%
Q1 2023$7,039
+27.1%
4680.0%0.00%
Q4 2022$5,536
+84.5%
4680.0%0.00%
Q3 2022$3,000
+50.0%
4680.0%0.00%
Q2 2022$2,000
-33.3%
468
+51.0%
0.00%
Q1 2022$3,000
-40.0%
310
+19.2%
0.00%
Q4 2021$5,000
-44.4%
2600.0%0.00%
Q3 2021$9,0002600.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Lion Point Capital, LP 839,128$27,926,0005.24%
RA Capital Management 4,098,332$136,392,0001.89%
KLK CAPITAL MANAGEMENT LLC 45,762$1,523,0001.40%
Antara Capital LP 520,800$17,332,0001.33%
Spotlight Asset Group, Inc. 75,000$2,496,0001.24%
Nicholas Investment Partners, LP 485,838$16,169,0001.18%
MAVERICK CAPITAL LTD 3,296,451$109,706,0001.11%
SECTORAL ASSET MANAGEMENT INC 394,949$13,144,0001.09%
683 Capital Management, LLC 828,271$27,565,0001.08%
ACT CAPITAL MANAGEMENT, LLC 60,000$1,997,0001.04%
View complete list of TG THERAPEUTICS INC shareholders